NRx Pharmaceuticals

NRx Pharmaceuticals Secures Expanded FDA Fast Track Designation and Strategic Investments Amid Growth Plans

WILMINGTON, DE — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported its second-quarter financial results and announced a series of significant regulatory, clinical, and corporate developments that strengthen its position in the …

NRx Pharmaceuticals Secures Expanded FDA Fast Track Designation and Strategic Investments Amid Growth Plans Read More